C E Gillett
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- PARP inhibition in cancer therapy
Papers in
-
- Genomics and Chromatin Dynamics 2
- Molecular Biology Techniques and Applications 2
- Ubiquitin and proteasome pathways 1
- Oncology 6
- Cancer-related Molecular Pathways 3
- HER2/EGFR in Cancer Research 2
- Co-authors
- Fernando Schmitt (1 shared paper)R. J. Springall (1 shared paper)D Steele (1 shared paper)Andrew Tutt (2 shared papers)Alan Ashworth (1 shared paper)J. S. Reis-Filho (1 shared paper)Kay Savage (1 shared paper)Anne‐Marie Russell (1 shared paper)
- Journals
- British Journal of Cancer (2 papers)The Lancet (1 paper)Oncogene (1 paper)The Breast (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United KingdomPortugalBelgium
In The Last Decade
C E Gillett
8 papers receiving 725 citations
Peers
Comparison fields: 5 of 55
- Cancer Research 282
- Oncology 406
- Pathology and Forensic Medicine 93
- Genetics 149
- Molecular Biology 346
Countries citing papers authored by C E Gillett
This map shows the geographic impact of C E Gillett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C E Gillett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C E Gillett more than expected).
Fields of papers citing papers by C E Gillett
This network shows the impact of papers produced by C E Gillett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C E Gillett. The network helps show where C E Gillett may publish in the future.
Co-authors
The 25 scholars most cited alongside C E Gillett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 458 | |
| 2 | 1992 | 173 | |
| 3 | 1995 | 54 | |
| 4 | 2004 | 27 | |
| 5 | 1993 | 25 | |
| 6 | 1995 | 21 | |
| 7 | 2009 | 2 | |
| 8 | PIK3CA, AKT1 MUTATION AND HER2 AMPLIFICATION GENE SIGNATURES (GS) SUGGEST PREDOMINANTLY NEGATIVE FEEDBACK INHIBITION OF PI3K/AKT PATHWAY IN HUMAN BREAST CANCER (BC). | 2009 | 1 |
| 9 | 1998 | 1 |
About C E Gillett
C E Gillett is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Genetics and Cancer Research, having authored 9 papers that have together received 762 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Genomics and Chromatin Dynamics (2 papers), Molecular Biology Techniques and Applications (2 papers), HER2/EGFR in Cancer Research (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper), Estrogen and related hormone effects (1 paper), Ubiquitin and proteasome pathways (1 paper) and Genetic and rare skin diseases. (1 paper). The work is most often cited by research in Cancer Research (282 citations), Oncology (406 citations), Pathology and Forensic Medicine (93 citations), Genetics (149 citations) and Molecular Biology (346 citations). C E Gillett has collaborated with scholars based in United Kingdom, Portugal and Belgium. Frequent co-authors include Fernando Schmitt, R. J. Springall, D Steele, Andrew Tutt, Alan Ashworth, J. S. Reis-Filho, Kay Savage, Anne‐Marie Russell, Nicholas C. Turner and K W Ryder. Their work appears in journals such as British Journal of Cancer, The Lancet, Oncogene, The Breast and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.